Zavesca virker ved at hæmme et enzym, som kaldes ’ glucosylceramidsyntase ’, som er ansvarlig for det første trin i omdannelsen af de fleste glycosphingolipider.
Zavesca works by inhibiting the enzyme called ‘ glucosylceramide synthase’ which is responsible for the first step in the synthesis of most glycosphingolipids.